in 293 patients with previously untreated polycythaemia vera , two different treatment modalities were randomized : 32p ( 0.5-1 mci/10 kg at diagnosis and for each overt relapse ) versus busulfan ( 4-6 mg/day during 4-8 weeks , with re-administration at relapse ) .
C0032463
polycythaemia vera
C0006463
busulfan